vTv Therapeutics Inc. (VTVT) › Operating Cash FlowvTv Therapeutics Inc. (VTVT) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2016: -$48.21M2017: -$44.56M2018: -$26.86M2019: -$23.02M2020: -$18.00M2021: -$19.31M2022: -$16.02M2023: -$19.08M2024: -$25.31M2025: -$25.25M-$25.25M2016Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$25.25M+0.2%2024-$25.31M-32.6%2023-$19.08M-19.1%2022-$16.02M+17.0%2021-$19.31M-7.3%2020-$18.00M+21.8%2019-$23.02M+14.3%2018-$26.86M+39.7%2017-$44.56M+7.6%2016-$48.21M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share